Serological studies in inflammatory bowel disease: How important are they?

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Serum antibodies have the potential role to assist in the diagnosis, disease stratification and prognostication of inflammatory bowel disease (IBD). Understanding antibody formation might provide insight into the dysregulated immunological response to the gut microbiota in IBD. This review summarizes recent evidence regarding the role of serology in IBD. RECENT FINDINGS: There is accumulating evidence from cross-sectional and longitudinal studies and from recent meta-analyses that supports the value of serological markers in identifying patients with complicated disease phenotype and increased risk of surgery in patients with Crohn's disease. Anti-Saccharomyces cerevisiae antibody remains the most accurate single marker, and recently identified exocrine pancreas antibodies (GP2 and CUZD1) have been suggested as evidence for a role of antibodies in the pathogenesis of Crohn's disease. SUMMARY: Despite these various developments, the use of the serum antibodies remains complementary in clinical practice. New markers are being currently evaluated that may reflect events relevant to the pathogenesis of IBD.

Original languageEnglish
Pages (from-to)359-364
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume30
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Inflammatory Bowel Diseases
Antibodies
Crohn Disease
Exocrine Pancreas
Serology
Serum
Antibody Formation
Longitudinal Studies
Saccharomyces cerevisiae
Meta-Analysis
Cross-Sectional Studies
Phenotype

Keywords

  • Crohn's disease
  • Diagnosis
  • Pathogenesis
  • Prediction
  • Serological antibodies

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Serological studies in inflammatory bowel disease : How important are they? / Papp, M.; Lakatos, P.

In: Current Opinion in Gastroenterology, Vol. 30, No. 4, 2014, p. 359-364.

Research output: Contribution to journalArticle

@article{e139ef86c42447d0b2b3eccbe3f72e9c,
title = "Serological studies in inflammatory bowel disease: How important are they?",
abstract = "PURPOSE OF REVIEW: Serum antibodies have the potential role to assist in the diagnosis, disease stratification and prognostication of inflammatory bowel disease (IBD). Understanding antibody formation might provide insight into the dysregulated immunological response to the gut microbiota in IBD. This review summarizes recent evidence regarding the role of serology in IBD. RECENT FINDINGS: There is accumulating evidence from cross-sectional and longitudinal studies and from recent meta-analyses that supports the value of serological markers in identifying patients with complicated disease phenotype and increased risk of surgery in patients with Crohn's disease. Anti-Saccharomyces cerevisiae antibody remains the most accurate single marker, and recently identified exocrine pancreas antibodies (GP2 and CUZD1) have been suggested as evidence for a role of antibodies in the pathogenesis of Crohn's disease. SUMMARY: Despite these various developments, the use of the serum antibodies remains complementary in clinical practice. New markers are being currently evaluated that may reflect events relevant to the pathogenesis of IBD.",
keywords = "Crohn's disease, Diagnosis, Pathogenesis, Prediction, Serological antibodies",
author = "M. Papp and P. Lakatos",
year = "2014",
doi = "10.1097/MOG.0000000000000076",
language = "English",
volume = "30",
pages = "359--364",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Serological studies in inflammatory bowel disease

T2 - How important are they?

AU - Papp, M.

AU - Lakatos, P.

PY - 2014

Y1 - 2014

N2 - PURPOSE OF REVIEW: Serum antibodies have the potential role to assist in the diagnosis, disease stratification and prognostication of inflammatory bowel disease (IBD). Understanding antibody formation might provide insight into the dysregulated immunological response to the gut microbiota in IBD. This review summarizes recent evidence regarding the role of serology in IBD. RECENT FINDINGS: There is accumulating evidence from cross-sectional and longitudinal studies and from recent meta-analyses that supports the value of serological markers in identifying patients with complicated disease phenotype and increased risk of surgery in patients with Crohn's disease. Anti-Saccharomyces cerevisiae antibody remains the most accurate single marker, and recently identified exocrine pancreas antibodies (GP2 and CUZD1) have been suggested as evidence for a role of antibodies in the pathogenesis of Crohn's disease. SUMMARY: Despite these various developments, the use of the serum antibodies remains complementary in clinical practice. New markers are being currently evaluated that may reflect events relevant to the pathogenesis of IBD.

AB - PURPOSE OF REVIEW: Serum antibodies have the potential role to assist in the diagnosis, disease stratification and prognostication of inflammatory bowel disease (IBD). Understanding antibody formation might provide insight into the dysregulated immunological response to the gut microbiota in IBD. This review summarizes recent evidence regarding the role of serology in IBD. RECENT FINDINGS: There is accumulating evidence from cross-sectional and longitudinal studies and from recent meta-analyses that supports the value of serological markers in identifying patients with complicated disease phenotype and increased risk of surgery in patients with Crohn's disease. Anti-Saccharomyces cerevisiae antibody remains the most accurate single marker, and recently identified exocrine pancreas antibodies (GP2 and CUZD1) have been suggested as evidence for a role of antibodies in the pathogenesis of Crohn's disease. SUMMARY: Despite these various developments, the use of the serum antibodies remains complementary in clinical practice. New markers are being currently evaluated that may reflect events relevant to the pathogenesis of IBD.

KW - Crohn's disease

KW - Diagnosis

KW - Pathogenesis

KW - Prediction

KW - Serological antibodies

UR - http://www.scopus.com/inward/record.url?scp=84902278550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902278550&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000076

DO - 10.1097/MOG.0000000000000076

M3 - Article

C2 - 24811052

AN - SCOPUS:84902278550

VL - 30

SP - 359

EP - 364

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 4

ER -